Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jun 1;97(11):2680–2684. doi: 10.1172/JCI118718

Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase.

H Kubo 1, D Morgenstern 1, W M Quinian 1, P A Ward 1, M C Dinauer 1, C M Doerschuk 1
PMCID: PMC507356  PMID: 8647963

Abstract

Mice with chronic granulomatous disease (X-CGD mice) generated by mutating the X-linked gene for a subunit of NADPH oxidase have been analyzed for their ability to respond to intravenous injection of purified cobra venom factor (CVF). This agent in wild-type mice produces a neutrophil-dependent and catalase-sensitive form of lung injury. Lung injury was evaluated by measuring the accumulation of extravascular albumin. Quite unexpectedly, the lungs of X-CGD mice showed no difference in the increased accumulation of extravascular albumin after injection of CVF when compared to wild-type mice. In both X-CGD and wild-type mice, full development of injury required neutrophils. While catalase was highly protective in wild-type mice, its protective effects were completely lost in the X-CGD mice. Furthermore, a competitive antagonist of L-arginine, N(G)-methyl-L-arginine, was protective in X-CGD mice but not in wild-type mice. Allopurinol was protective in both types of mice. Both the basal and the CVF-inducible lung mRNA for inducible nitric oxide synthase and IL-1beta was similar in X-CGD and wild-type mice. These data indicate that oxygen radical production and lung injury in response to injection of CVF occurs through alternative pathways in mice with genetic deletion of NADPH oxidase.

Full Text

The Full Text of this article is available as a PDF (175.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bullard D. C., Qin L., Lorenzo I., Quinlin W. M., Doyle N. A., Bosse R., Vestweber D., Doerschuk C. M., Beaudet A. L. P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest. 1995 Apr;95(4):1782–1788. doi: 10.1172/JCI117856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chen L. Y., Mehta J. L. Variable effects of L-arginine analogs on L-arginine-nitric oxide pathway in human neutrophils and platelets may relate to different nitric oxide synthase isoforms. J Pharmacol Exp Ther. 1996 Jan;276(1):253–257. [PubMed] [Google Scholar]
  3. Dinauer M. C., Orkin S. H. Chronic granulomatous disease. Annu Rev Med. 1992;43:117–124. doi: 10.1146/annurev.me.43.020192.001001. [DOI] [PubMed] [Google Scholar]
  4. KEILIN D., HARTREE E. F. Catalase, peroxidase and metmyoglobin as catalysts of coupled peroxidatic reactions. Biochem J. 1955 Jun;60(2):310–325. doi: 10.1042/bj0600310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kukreja R. C., Hess M. L. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res. 1992 Jul;26(7):641–655. doi: 10.1093/cvr/26.7.641. [DOI] [PubMed] [Google Scholar]
  6. Kume A., Dinauer M. C. Retrovirus-mediated reconstitution of respiratory burst activity in X-linked chronic granulomatous disease cells. Blood. 1994 Nov 15;84(10):3311–3316. [PubMed] [Google Scholar]
  7. Massey V., Komai H., Palmer G., Elion G. B. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines. J Biol Chem. 1970 Jun 10;245(11):2837–2844. [PubMed] [Google Scholar]
  8. Mulligan M. S., Paulson J. C., De Frees S., Zheng Z. L., Lowe J. B., Ward P. A. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature. 1993 Jul 8;364(6433):149–151. doi: 10.1038/364149a0. [DOI] [PubMed] [Google Scholar]
  9. Mulligan M. S., Polley M. J., Bayer R. J., Nunn M. F., Paulson J. C., Ward P. A. Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J Clin Invest. 1992 Oct;90(4):1600–1607. doi: 10.1172/JCI116029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mulligan M. S., Smith C. W., Anderson D. C., Todd R. F., 3rd, Miyasaka M., Tamatani T., Issekutz T. B., Ward P. A. Role of leukocyte adhesion molecules in complement-induced lung injury. J Immunol. 1993 Mar 15;150(6):2401–2406. [PubMed] [Google Scholar]
  11. Mulligan M. S., Varani J., Warren J. S., Till G. O., Smith C. W., Anderson D. C., Todd R. F., 3rd, Ward P. A. Roles of beta 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury. J Immunol. 1992 Mar 15;148(6):1847–1857. [PubMed] [Google Scholar]
  12. Mulligan M. S., Watson S. R., Fennie C., Ward P. A. Protective effects of selectin chimeras in neutrophil-mediated lung injury. J Immunol. 1993 Dec 1;151(11):6410–6417. [PubMed] [Google Scholar]
  13. Mulligan M. S., Yeh C. G., Rudolph A. R., Ward P. A. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. J Immunol. 1992 Mar 1;148(5):1479–1485. [PubMed] [Google Scholar]
  14. Nakayama D. K., Geller D. A., Lowenstein C. J., Chern H. D., Davies P., Pitt B. R., Simmons R. L., Billiar T. R. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am J Respir Cell Mol Biol. 1992 Nov;7(5):471–476. doi: 10.1165/ajrcmb/7.5.471. [DOI] [PubMed] [Google Scholar]
  15. Pollock J. D., Williams D. A., Gifford M. A., Li L. L., Du X., Fisherman J., Orkin S. H., Doerschuk C. M., Dinauer M. C. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet. 1995 Feb;9(2):202–209. doi: 10.1038/ng0295-202. [DOI] [PubMed] [Google Scholar]
  16. Pryor W. A., Squadrito G. L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 1995 May;268(5 Pt 1):L699–L722. doi: 10.1152/ajplung.1995.268.5.L699. [DOI] [PubMed] [Google Scholar]
  17. Sakuma I., Stuehr D. J., Gross S. S., Nathan C., Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8664–8667. doi: 10.1073/pnas.85.22.8664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Till G. O., Friedl H. P., Ward P. A. Lung injury and complement activation: role of neutrophils and xanthine oxidase. Free Radic Biol Med. 1991;10(6):379–386. doi: 10.1016/0891-5849(91)90046-6. [DOI] [PubMed] [Google Scholar]
  19. Till G. O., Johnson K. J., Kunkel R., Ward P. A. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest. 1982 May;69(5):1126–1135. doi: 10.1172/JCI110548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tvedten H. W., Till G. O., Ward P. A. Mediators of lung injury in mice following systemic activation of complement. Am J Pathol. 1985 Apr;119(1):92–100. [PMC free article] [PubMed] [Google Scholar]
  21. Varani J., Phan S. H., Gibbs D. F., Ryan U. S., Ward P. A. H2O2-mediated cytotoxicity of rat pulmonary endothelial cells. Changes in adenosine triphosphate and purine products and effects of protective interventions. Lab Invest. 1990 Nov;63(5):683–689. [PubMed] [Google Scholar]
  22. Varani J., Ward P. A. Mechanisms of neutrophil-dependent and neutrophil-independent endothelial cell injury. Biol Signals. 1994 Jan-Feb;3(1):1–14. doi: 10.1159/000109521. [DOI] [PubMed] [Google Scholar]
  23. Ward P. A., Mulligan M. S. Molecular mechanisms in acute lung injury. Adv Pharmacol. 1993;24:275–292. doi: 10.1016/s1054-3589(08)60940-0. [DOI] [PubMed] [Google Scholar]
  24. Ward P. A., Till G. O., Kunkel R., Beauchamp C. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J Clin Invest. 1983 Sep;72(3):789–801. doi: 10.1172/JCI111050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ward P. A., Varani J. Mechanisms of neutrophil-mediated killing of endothelial cells. J Leukoc Biol. 1990 Jul;48(1):97–102. doi: 10.1002/jlb.48.1.97. [DOI] [PubMed] [Google Scholar]
  26. Warner R. L., Paine R., 3rd, Christensen P. J., Marletta M. A., Richards M. K., Wilcoxen S. E., Ward P. A. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol. 1995 Jun;12(6):649–661. doi: 10.1165/ajrcmb.12.6.7539274. [DOI] [PubMed] [Google Scholar]
  27. Yan L., Vandivier R. W., Suffredini A. F., Danner R. L. Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J Immunol. 1994 Aug 15;153(4):1825–1834. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES